A research study in which new ways to prevent, detect, diagnose, or treat disease are tested on human participants.
The second session of 'What Does Genomics Mean for Fertility Treatment?' – the 2025 Annual Conference of PET – explored controversies surrounding preimplantation genetic testing for aneuploidy...
Eleven people with aggressive T-cell leukaemia have now received a 'base editing' therapy, with seven remaining in remission up to three years after treatment...
Rare genetic variants in a single gene appear to increase the risk of developing mental health conditions, according to a new study...
A genome editing therapy robustly reduces harmful cholesterol levels in patients, according to data released from a Phase I clinical trial...
Dr Jess Buxton attended PET's most recent event, which discussed how to improve diagnosis, treatment and support for people affected by rare and inherited metabolic diseases...
Children with a fatal brain disorder showed significant improvements after receiving gene therapy in an early-stage clinical trial...
The UK government has committed to accelerating the development and approval of treatments for rare diseases, through major reforms to current regulation...
Two gene therapy trials run by Intellia Therapeutics have been paused after a study participant was hospitalised...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
